GW Pharmaceuticals PLC
SEC CIK 1351288 · GWPH · last insider filing 2021-05-07
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Gryska David W | Director | filed 2020 - 2021 |
| Noble James | Director | filed 2018 - 2021 |
| Secor Alicia | Director | filed 2018 - 2021 |
| Mackey Catherine J | Director | filed 2018 - 2021 |
| Knappertz Volker | Director · Chief Medical Officer | filed 2018 - 2021 |
| Gover Justin D. | Director · Chief Executive Officer | filed 2018 - 2021 |
| Waldegrave William A. | Director | filed 2018 - 2021 |
| Brown Cabot | Director | filed 2018 - 2021 |
| GUY Geoffrey W DR | Director · Executive Chairman | filed 2018 - 2021 |
| Lynch Thomas G | Director | filed 2018 - 2019 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Cline Darren S | U.S. Chief Commercial Officer | filed 2019 - 2021 |
| Snyder Douglas B. | Chief Legal Officer | filed 2018 - 2021 |
| Giacobello Scott M. | Chief Financial Officer | filed 2018 - 2021 |
| Tovey Christopher J. | Chief Operating Officer | filed 2018 - 2021 |
| George Adam D. | Secretary | filed 2018 - 2021 |
| Gangolli Julian S | President, North America | filed 2018 - 2019 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.